Literature DB >> 1784886

Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus. Members of the SLE Study Group.

K Hartung1, R Coldewey, E Röther, K Pirner, C Specker, D Schendel, W Stangel, S Stannat-Kiessling, G G de Lange.   

Abstract

Immunoglobulin heavy chain (G1m, G2m, G3m, A2m) and kappa light chain (Km) allotype and phenotype frequencies of 323 central European Caucasian patients with systemic lupus erythematosus (SLE) were examined and correlated with various genetic, serologic and clinical markers of SLE. No significant associations were found between immunoglobulin allotypes or phenotypes and all 20 parameters tested (nephritis, vasculitis, arthralgias, photosensitivity, discoid lesions, central nervous system disease, Raynaud's phenomenon, sex, anti-Ro, anti-La, anti-nRNP, HLA-DR1-DR7, HLA phenotypes B8-DR3, B7-DR2). It could therefore be assumed that Gm, A2m and Km allotypes were not associated with HLA-antigens and had no influence on the serologic and clinical expression of SLE.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784886     DOI: 10.1007/bf00332558

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  24 in total

1.  Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.

Authors:  E Ben-Chetrit; R I Fox; E M Tan
Journal:  Arthritis Rheum       Date:  1990-03

2.  Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis.

Authors:  V Stenszky; L Kozma; G Szegedi; N R Farid
Journal:  J Immunogenet       Date:  1986-02

3.  Gm allotypes in white patients with systemic lupus erythematosus.

Authors:  P H Schur; J P Pandey; J A Fedrick
Journal:  Arthritis Rheum       Date:  1985-07

4.  Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus.

Authors:  A Alvarellos; J M Ahearn; T T Provost; C A Dorsch; M B Stevens; W B Bias; F C Arnett
Journal:  Arthritis Rheum       Date:  1983-12

5.  Genetic deficiency of C4, C2 or C1q and lupus syndromes. Association with anti-Ro (SS-A) antibodies.

Authors:  O Meyer; G Hauptmann; G Tappeiner; H D Ochs; F Mascart-Lemone
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

6.  Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens.

Authors:  D A Bell; P J Maddison
Journal:  Arthritis Rheum       Date:  1980-11

7.  Immunoglobulin allotypes in systemic lupus erythematosus--results of a central European multicenter study. SLE Study Group.

Authors:  K Hartung; R Coldewey; E Röther; K Pirner; C Specker; H H Peter; J R Kalden; H J Lakomek; H Deicher; G G de Lange
Journal:  Exp Clin Immunogenet       Date:  1991

8.  Association between a T cell receptor restriction fragment length polymorphism and systemic lupus erythematosus.

Authors:  J G Tebib; J Alcocer-Varela; D Alarcon-Segovia; P H Schur
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

9.  Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.

Authors:  A H Fielder; M J Walport; J R Batchelor; R I Rynes; C M Black; I A Dodi; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-05

10.  Anti-Ro(SSA) autoantibodies are associated with T cell receptor beta genes in systemic lupus erythematosus patients.

Authors:  M B Frank; R McArthur; J B Harley; A Fujisaku
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.